1. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells
    Xiaojing Li et al, 2019, European Journal of Pharmacology CrossRef
  2. Overexpression of microRNA‑21 inhibits the growth and metastasis of melanoma cells by targeting MKK3
    Meng Zhou et al, 2019, Molecular Medicine Reports CrossRef
  3. Detailed role of microRNA‐mediated regulation of PI3K/AKT axis in human tumors
    Sulieman Ibraheem Shelash Al‐Hawary et al, 2024, Cell Biochemistry and Function CrossRef
  4. CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
    Li Q. Zhang et al, 2019, Technology in Cancer Research & Treatment CrossRef
  5. Celastrol Suppresses Tryptophan Catabolism in Human Colon Cancer Cells as Revealed by Metabolic Profiling and Targeted Metabolite Analysis
    Yunpeng Qi et al, 2018, Biological and Pharmaceutical Bulletin CrossRef
  6. SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process
    Chiara Lambona et al, 2024, Journal of Medicinal Chemistry CrossRef
  7. Influence of GO-Antisense miRNA-21 on the Expression of Selected Cytokines at Glioblastoma Cell Lines
    Marta Kutwin et al, 2023, International Journal of Nanomedicine CrossRef
  8. Celastrol inhibits cancer metastasis by suppressing M2-like polarization of macrophages
    Yuening Yang et al, 2018, Biochemical and Biophysical Research Communications CrossRef

  9. Tripterine Restrains the Aggressiveness of Hepatocellular Carcinoma Cell via Regulating miRNA-532-5p/CXCL2 Axis


    Zhi Tao Jiang et al, 2020, OncoTargets and Therapy CrossRef
  10. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
    Cheng Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  11. Functional metabolome profiling may improve individual outcomes in colorectal cancer management implementing concepts of predictive, preventive, and personalized medical approach
    Yu Yuan et al, 2022, EPMA Journal CrossRef
  12. Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo
    Li-Na Xu et al, 2019, Frontiers in Oncology CrossRef
  13. Celastrol upregulated ATG7 triggers autophagy via targeting Nur77 in colorectal cancer
    Wenxin Zhang et al, 2022, Phytomedicine CrossRef
  14. An oncolytic herpes simplex virus type 1 strain expressing a single-chain variable region antibody fragment against PD-1 and a PI3K inhibitor synergize to elicit antitumor immunity in ovarian cancer
    Shanying Huang et al, 2023, Archives of Virology CrossRef
  15. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment
    Jorge A.R. Salvador et al, 2017, European Journal of Medicinal Chemistry CrossRef
  16. Celastrol protects human retinal pigment epithelial cells against hydrogen peroxide mediated oxidative stress, autophagy, and apoptosis through sirtuin 3 signal pathway
    Zhaojiang Du et al, 2019, Journal of Cellular Biochemistry CrossRef
  17. DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies
    Mohammad Mirza-Aghazadeh-Attari et al, 2019, DNA Repair CrossRef

  18. MicroRNA-21-3p Engineered Umbilical Cord Stem Cell-Derived Exosomes Inhibit Tendon Adhesion


    Zhixiao Yao et al, 2020, Journal of Inflammation Research CrossRef
  19. Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review
    Tian-Jia Liu et al, 2021, Frontiers in Oncology CrossRef